FDA Investigator Wr Bowman
Wr Bowman has inspections in 3 countries as of 09 Jun 2023. Wr Bowman has collaborated with a combinined 2368 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
63
Last Inspection Date:
09 Jun 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
India,
Canada
Co-Investigator(s):
A Williams,
Alan M Stevens,
Alexandra B Pitkin,
Allen F Hall,
Amanda E Lewin, PhD,
Anderson,
Andrews,
Bailey A Uetrecht,
Barbara A Rusin,
Barbara M Frazier,
Barbara M Frezior,
Bowman,
Bruce R Burrell,
Bush,
Carol B Czerniak,
Carr Sharpe,
Cathryn M Groehnert,
CDR Sean T Creighton,
Celena Ngo,
Charles L Larson,
Christine I Shaw,
Christopher M Elliott,
Corey A Cruse,
Courtney N Long,
Dannie E Rowland,
Darrin E Davis,
David G Whitman,
David Kalins,
Davis,
Debra D Devlieger,
Debra J Fracassa,
Desiree C Iya,
Diana M Rand,
Donna Ltartaglino Besone,
Dr. Sriram Subramaniam, PhD,
Durell L Giles,
Eileen T Dupont,
Elizabeth A Dakan,
Elizabeth M Dahl,
Erik D Sandvig,
Finn A Slizza,
Finn Sizza (Alex),
Francisco,
Garciam,
Gene D Arcy,
Geoffrey K Kilili,
Greg K Keshishyan,
Gulshan R Anand,
Hagstrom,
Harperd,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Hyojong Kwon, PhD,
Ian A Pilcher,
Iris C Macinnes,
Ivar J Sohn,
Jake T Lane,
James A Barreto,
James R Fleckenstein,
Jamie M Du,
Janet Janet,
Janet Pulver,
Jeffrey P Raimondi,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Jocelyn E Sparks,
Joey V Quitania,
John A Kadavil, PhD,
John R Myung,
Joseph H Lam,
Juanj N Wu,
Juanj Wu,
Judy C Nepsa,
Ka L Wong,
Kai Wang,
Katherine E Jacobitz,
Kelvin Cheung,
Kelvin X Sanders,
Kip J Hanks,
Kirtida Patel,
Lakecha N Lewis,
Laurissa S Flowers,
Leonard H Lavi,
Li Hongpaul Yeh, PhD,
Lilly O Barton,
Linda Linhn Adams,
Linda R Kuchenthal,
Lori A Gioia,
Mageet,
Marc G Bellaire,
Marcus F Yambot,
Maria Isabetejerodel Rio,
Mark C Saale,
Mark W Babbitt,
Marlo Ianm Alintanahin,
Matthew C Kristof,
Matthew J Gretkierewicz,
Matthew M Vernon,
Maurice M Sheehan,
Mei Chen Mu,
Michael P Dimaano,
Michael S Call,
Natalie J Ayoub,
Nianna C Burns,
Nicholas J Lahey,
Rebecca T Davis,
Richard W Tubb,
Robert C Hoover,
Rodney T Allnutt,
Ruben C Ayala, PharmD,
Sandersk,
Sarah A Hassas,
Scott B Laufenberg,
Scott K Zika,
Sean P Desbrow,
Selene T Torres,
Shaquenta Y Perkins,
Sonya L Karsik,
Srlram Subramaniam, PhD,
Stacie A Woods,
State Agency,
Stephen R Souza,
Sundy Ven,
Sunita Vij,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Tamara L Alexander,
Tanya E Malais,
Tawny L Colling,
Thanh M Andrews,
Thao T Kwan,
Truong Xuan Nguyen (Andy),
Trushani T Desai,
Uttaniti Limchumroon (Tom),
Vickie L Anderson,
Victor H Loo,
Virgilio F Pacio, CSO,
Yumi J Hiramine,
Yvette E Guillermo,
Zachary A Bogorad
Wr Bowman's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2000 | EIR | Michael B. Limberg - EIR, 2000-02-14 |
| January, 2000 | FDA 483 | Medtronic MiniMed - Form 483, 2000-01-10 |
| June, 2004 | EIR | Medtronic MiniMed, Inc. - EIR, 2007-12-21 |
| February, 2000 | FDA 483 | Limberg Eye Center - Form 483, 2000-02-14 |
| September, 2008 | FDA 483 | ACCUTEST RESEARCH LABORATORIES ( I ) - Form 483, 2008-09-01 |
| April, 2001 | FDA 483 | CareFusion 303, Inc. - Form 483, 2001-04-12 |
| November, 2002 | FDA 483 | BELPORT COMPANY, INC. - Form 483, 2002-11-14 |
| April, 2001 | EIR | CareFusion 303, Inc. - EIR, 2001-04-12 |
| April, 2002 | EIR | Allergan - EIR, 2002-04-05 |
| October, 2001 | FDA 483 | Bio Science Technologies Inc - Form 483, 2001-10-29 |
| September, 2008 | EIR | ACCUTEST RESEARCH LABORATORIES ( I ) - EIR, 2008-10-16 |
| October, 2001 | EIR | Bio Science Technologies Inc - EIR, 2001-10-29 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more